Biomarker Application for Precision Medicine in Stroke

Alexis N. Simpkins, Miroslaw Janowski, Helieh S. Oz, Jill Roberts, Gregory Bix, Sylvain Doré, Ann M. Stowe

Research output: Contribution to journalReview articlepeer-review

55 Scopus citations


Stroke remains one of the leading causes of long-term disability and mortality despite recent advances in acute thrombolytic therapies. In fact, the global lifetime risk of stroke in adults over the age of 25 is approximately 25%, with 24.9 million cases of ischemic stroke and 18.7 million cases of hemorrhagic stroke reported in 2015. One of the main challenges in developing effective new acute therapeutics and enhanced long-term interventions for stroke recovery is the heterogeneity of stroke, including etiology, comorbidities, and lifestyle factors that uniquely affect each individual stroke survivor. In this comprehensive review, we propose that future biomarker studies can be designed to support precision medicine therapeutic interventions after stroke. The current challenges in defining ideal biomarkers for stroke are highlighted, including consideration of disease course, age, lifestyle factors, and subtypes of stroke. This overview of current clinical trials includes biomarker collection, and concludes with an example of biomarker design for aneurysmal subarachnoid hemorrhage. With the advent of “-omics” studies, neuroimaging, big data, and precision medicine, well-designed stroke biomarker trials will greatly advance the treatment of a disease that affects millions globally every year.

Original languageEnglish
Pages (from-to)615-627
Number of pages13
JournalTranslational Stroke Research
Issue number4
StatePublished - Aug 1 2020

Bibliographical note

Funding Information:
We would like to thank Dr. Tony Parker, Queensland University of Technology, plus the organizers and attendees of the University of Kentucky’s STRAW (Stroke Translational Research Advancement Workshop) for contribution to initial discussions held on October 24 and 25, 2018, in Lexington, KY, USA.

Funding Information:
This effort was also partially supportedby grants from the National Institutes of Health (R21NS095166 (SD), R01NS091100 (MJ)) and the American Heart Association (17GRNT33450010 (SD), 19EIA34760279 (AMS)).

Publisher Copyright:
© 2019, The Author(s).


  • 'omics'
  • big data
  • biomarker
  • clinical trials
  • hemorrhagic stroke
  • ischemic stroke
  • precision medicine

ASJC Scopus subject areas

  • Neuroscience (all)
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Biomarker Application for Precision Medicine in Stroke'. Together they form a unique fingerprint.

Cite this